Iace and colorectal cancer disparities: Health-care utilization vs different cancer susceptibilities

Journal of the National Cancer Institute

Volumn 102, Issue 8, 2010, Pages 538-546

  Laiyemo, Adeyinka O ^a,b   Doubeni, Chyke ^c   Pinsky, Paul F ^b   Doria Rose, V Paul ^b   Bresalier, Robert ^d   Lamerato, Lois E ^e   Crawford, E David ^f   Kvale, Paul ^e   Fouad, Mona ^g   Hickey, Thomas ^h   Riley, Thomas ^h   Weissfeld, Joel ⁱ   Schoen, Robert E ⁱ   Marcus, Pamela M ^b   Prorok, Philip C ^b   Berg, Christine D ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g University of Alabama at Birmingham   (United States)

^h INFORMATION MANAGEMENT SERVICES INC   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; ETHNIC DIFFERENCE; FEMALE; FLEXIBLE SIGMOIDOSCOPY; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGMOIDOSCOPY; AFRICAN AMERICAN; CAUCASIAN; COLORECTAL TUMOR; EARLY DIAGNOSIS; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; INCIDENCE; LUNG TUMOR; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; OVARY TUMOR; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SOCIOECONOMICS; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

AFRICAN AMERICANS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SIGMOIDOSCOPY; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 77951639959     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq068     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. (Pubitemid 351521864)
2. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005.Bethesda, MD: National Cancer Institute; 2008. Based on November 2007 SEER data submission, posted to the SEER Web site. http://seer.cancer.gov/csr/ 1975-2005/. Accessed March 24, 2009.
3. Siegel RL, Jemal A, Thun MJ, Hao Y, Ward EM. Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc. 2008;100(12):1441-1444.
4. Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst. 2008;100(14):1003-1012. (Pubitemid 352019798)
5. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109(3):612-620. (Pubitemid 46190971)
6. Fairley TL, Cardinez CJ, Martin J, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer. 2006;107(5 suppl):1153-1161. (Pubitemid 44384821)
7. Shavers VL. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc. 2007;99(7):733-748. (Pubitemid 47076141)
8. Johnson H Jr., Carstens R. Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer. 1986;58(4):997-1000. (Pubitemid 16035308)
9. Francois F, Park J, Bini EJ. Colon pathology detected after a positive screening flexible sigmoidoscopy: a prospective study in an ethnically diverse cohort. Am J Gastroenterol. 2006;101(4):823-830.
10. Agrawal S, Bhupinderjit A, Bhutani MS, et al. Committee of Minority Affairs and Cultural Diversity, American College of Gastroenterology. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100(3):515-523.
11. Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007;99(7):723-728. (Pubitemid 47076140)
12. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300(12):1417-1422.
13. Ramsoekh D, van Leerdam ME, van Ballegooijen M, Habbema JD, Kuipers EJ. Population screening for colorectal cancer: faeces, endoscopes or X-rays? Cell Oncol. 2007;29(3):185-194. (Pubitemid 46855700)
14. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(suppl):S309.
15. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21(6 suppl):251S-272S.
16. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO Cancer Screening Trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst. 2005;97(13):989-997.
17. Stallings FL, Ford ME, Simpson NK, et al. Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 suppl):379S-389S.
18. Pinsky PF, Ford M, Gamito E, et al. Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc. 2008;100(3):291-298. (Pubitemid 351441236)
19. Pinsky PF, Schoen RE, Weissfeld JL, Kramer B, Hayes RB, Yokochi L. PLCO Project Team. Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol. 2005;3(8):792-797. (Pubitemid 41116732)
20. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129-2135. (Pubitemid 41434589)
21. Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev. 2009; 18(8): 2170-2175.
22. Haas JS, Earle CC, Orav JE, Brawarsky P, Neville BA, Williams DR. Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med. 2008;23(5):699-705.
23. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690-1691. (Pubitemid 28532993)
24. Deddens JA, Petersen MR, Lei X. Estimation of prevalence ratios when PROC GENMOD does not converge (paper 270-28). Proceedings of the 28th Annual SAS Users Group International conference. Cary, NC: SAS Institute, Inc; 2003.
25. Deddens JA, Petersen MR. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes". Am J Epidemiol. 2004;159(2):213-214.
26. Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-Access medical system. Cancer. 1998;82(12):2312-2320. (Pubitemid 28283436)
27. McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African Americans and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002;94(15):1160-1167. (Pubitemid 34919053)
28. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211-1220. (Pubitemid 41258227)
29. Farjah F, Wood DE, Yanez ND III, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009;144(1):14-18.
30. Garland AF, Lau AS, Yeh M, McCabe KM, Hough RL, Landsverk JA. Racial and ethnic differences in utilization of mental health services among high-risk youths. Am J Psychiatry. 2005;162(7):1336-1343. (Pubitemid 40905585)
31. Sharma S, O'Keefe SJ. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J. 2007;83(983):583-589. (Pubitemid 47425609)
32. Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs. 1995;18:385-392.
33. Jandorf L, Fatone A, Borker PV, et al. Creating alliances to improve cancer prevention and detection among urban medically underserved minority groups. The East Harlem Partnership for Cancer Awareness. Cancer. 2006;107(8 suppl):2043-2051. (Pubitemid 44571927)
34. Pinsky PF, Miller A, Kramer BS, et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2007;165(8):874-881. (Pubitemid 46536660)
35. Lieberman D, Moravec M, Holub J, Michaels L, Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135(4):1100-1105.
36. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3):169-174. (Pubitemid 30489213)
37. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343(3):162-168. (Pubitemid 30489212)
38. Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol. 2008;6(9):1011-1015.